Pepgen Limited (11170794) is a private limited with share capital incorporated on 25/01/2018 (8 years old) and registered in huntingdon, PE282AF. The company operates under SIC code 72110 and is classified as Unknown.
Our ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of our innovative product engine. pepgen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and we are advancing novel co...
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:18-11-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:08-06-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-05-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:12-04-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:12-04-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:06-12-2021
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:16-09-2021
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:16-09-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:28-06-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:24-06-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:24-06-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:24-06-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:24-06-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:24-06-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:17-06-2021
Capital Allotment Shares
Category:Capital
Date:13-11-2020
Change Person Director Company With Change Date
Category:Officers
Date:04-08-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:03-08-2020
Termination Director Company With Name Termination Date
Category:Officers
Date:31-07-2020
Accounts With Accounts Type Unaudited Abridged
Category:Accounts
Date:15-07-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-05-2020
Termination Director Company With Name Termination Date
Category:Officers
Date:10-03-2020
Resolution
Category:Resolution
Date:14-02-2020
Capital Allotment Shares
Category:Capital
Date:03-01-2020
Capital Allotment Shares
Category:Capital
Date:02-01-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:04-11-2019
Appoint Person Director Company With Name Date
Category:Officers
Date:04-11-2019
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:06-10-2019
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:29-05-2019
Change Person Director Company With Change Date
Category:Officers
Date:29-05-2019
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:22-03-2019
Change Account Reference Date Company Current Shortened
Category:Accounts
Date:12-09-2018
Confirmation Statement With Updates
Category:Confirmation Statement
Date:17-05-2018
Capital Allotment Shares
Category:Capital
Date:24-04-2018
Capital Allotment Shares
Category:Capital
Date:24-04-2018
Capital Alter Shares Subdivision
Category:Capital
Date:18-04-2018
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:05-04-2018
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:05-04-2018
Resolution
Category:Resolution
Date:04-04-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:29-03-2018
Appoint Person Director Company With Name Date
Category:Officers
Date:29-03-2018
Incorporation Company
Category:Incorporation
Date:25-01-2018
Innovate Grants
1
This company received a grant of £1600000.57 for Application Of A Novel Peptide Delivery Platform To Nucleic Acid Therapeutics In Degenerative And Rare Diseases. The project started on 01/02/2019 and ended on 31/03/2021.